Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/25/2000 | WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof |
05/25/2000 | WO2000029437A1 HYPOXIA-INDUCIBLE FACTOR 1α HIF-1α VARIANTS AND METHODS FOR IDENTIFYING HIF-1α MODULATORS |
05/25/2000 | WO2000029436A1 Protein amsh and cdna thereof |
05/25/2000 | WO2000029435A1 12 human secreted proteins |
05/25/2000 | WO2000029432A1 Heliobacter pylori antigen |
05/25/2000 | WO2000029430A1 Ring finger protein zapop3 |
05/25/2000 | WO2000029429A2 Endoplasmic reticulum stress transcription factors atf6 and creb-rp |
05/25/2000 | WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy |
05/25/2000 | WO2000029427A2 Antennapedia homeodomain helix 3 derived translocation vectors |
05/25/2000 | WO2000029423A1 G protein-coupled receptor resembling the leukotriene b4 receptor |
05/25/2000 | WO2000029422A1 31 human secreted proteins |
05/25/2000 | WO2000029421A1 Selection system for generating efficient packaging cells for lentiviral vectors |
05/25/2000 | WO2000029420A2 Methods of making modified nucleosides |
05/25/2000 | WO2000029103A1 Method and apparatus for liposome production |
05/25/2000 | WO2000029032A1 Methods for using heat shock proteins bound to dna or rna |
05/25/2000 | WO2000029031A1 Nucleic acid transporters and medicinal compositions for gene therapy |
05/25/2000 | WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase |
05/25/2000 | WO2000029012A2 Methods of alleviating cancer symptoms |
05/25/2000 | WO2000029008A2 Hiv-specific t-cell induction |
05/25/2000 | WO2000029004A1 Small functional units of antibody heavy chain variable regions |
05/25/2000 | WO2000029000A1 Compositions and methods for recombinational cloning of nucleic acid molecules |
05/25/2000 | WO2000028811A1 Animal model for neurological disorders |
05/25/2000 | WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
05/25/2000 | WO2000018920A3 Tmof receptor and uses thereof |
05/25/2000 | WO2000017372A3 Pineapple mealybug-associated wilt virus proteins and their uses |
05/25/2000 | WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
05/25/2000 | WO2000015818A3 Plant prohibitin genes and their use |
05/25/2000 | WO2000015816A3 Maize replication protein a |
05/25/2000 | WO2000015804A3 Method for production of peroxidases by use of a genetically modified host |
05/25/2000 | WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9) |
05/25/2000 | WO2000015788A3 Dna sequence encoding oncofetal ferritin protein |
05/25/2000 | WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
05/25/2000 | WO2000015209A3 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
05/25/2000 | WO2000014276A3 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids |
05/25/2000 | WO2000014228A8 Neutral amino acid transporter and gene thereof |
05/25/2000 | WO2000014227A8 Novel protein and dna thereof |
05/25/2000 | WO2000014205A3 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
05/25/2000 | WO2000012111A3 Selective treatment of endothelial somatostatin receptors |
05/25/2000 | WO2000009724A9 Transgenic plants expressing a mapkkk protein kinase domain |
05/25/2000 | WO2000009543A3 Hepatitis c inhibitor tri-peptides |
05/25/2000 | WO2000009148A9 Vascular endothelial growth factor 3 |
05/25/2000 | WO2000008924A9 Method of performing transgenesis |
05/25/2000 | WO2000008443A9 Multiple frequency fluorescence lifetime imaging |
05/25/2000 | WO2000008194A3 Cell lines for the propagation of mutated herpes viruses |
05/25/2000 | WO2000008153A3 Arf-p19, a novel regulator of the mammalian cell cycle |
05/25/2000 | WO2000007545A8 Apoptosis proteins |
05/25/2000 | WO2000004051A3 Growth differentiation factor promoter and uses therefor |
05/25/2000 | WO2000001801A9 Ftsz multimeric proteins and their uses |
05/25/2000 | WO1999051762A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
05/25/2000 | WO1998049350A8 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes |
05/25/2000 | DE19913934C1 Production of a random primed DNA for targeted cloning, especially for qualitative gene libraries to analyze central mutations of organisms |
05/25/2000 | DE19853726A1 Molecular biological method for solving NP problems, useful e.g. in economics, by sequential assembly of DNA fragments and examining products for one of appropriate length |
05/25/2000 | DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases |
05/25/2000 | DE19850186A1 Neue Primer und Sonden zum Nachweis von HIV New primers and probes for the detection of HIV |
05/25/2000 | DE19840263C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
05/25/2000 | CA2803417A1 Selection system for generating efficient packaging cells for lentiviral vectors |
05/25/2000 | CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
05/25/2000 | CA2353076A1 Ligation assembly and detection of polynucleotides on solid-support |
05/25/2000 | CA2352463A1 Methods using genetic package display for detecting and identifying protein-protein interactions |
05/25/2000 | CA2351891A1 Analytical system based upon spore germination |
05/25/2000 | CA2351881A1 A whole-genome radiation hybrid map of the dog genome and use thereof for identifying genes of interest |
05/25/2000 | CA2351874A1 G protein-coupled receptor resembling the leukotriene b4 receptor |
05/25/2000 | CA2351740A1 Method for the quantitative detection of nucleic acids |
05/25/2000 | CA2351729A1 Cell surface receptor antigen vaccines |
05/25/2000 | CA2351669A1 Small functional units of antibody heavy chain variable regions |
05/25/2000 | CA2351629A1 Nucleic acid carriers and pharmaceutical compositions for gene therapy |
05/25/2000 | CA2351622A1 Polypeptide |
05/25/2000 | CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
05/25/2000 | CA2351566A1 Gene coding for an acyltranferase of oil seed rape and uses thereof |
05/25/2000 | CA2351550A1 Phosphonate metabolizing plants |
05/25/2000 | CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines |
05/25/2000 | CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof |
05/25/2000 | CA2351314A1 Novel recombinant adenovirus |
05/25/2000 | CA2351313A1 Immunoglobulin superfamily proteins |
05/25/2000 | CA2351312A1 Novel human wnt gene |
05/25/2000 | CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
05/25/2000 | CA2351022A1 Low cost manufacture of oligosaccharides |
05/25/2000 | CA2350919A1 Antennapedia homeodomain helix 3 derived translocation vectors |
05/25/2000 | CA2350917A1 Contraceptive antibody vaccines |
05/25/2000 | CA2350911A1 Hiv-specific t-cell induction |
05/25/2000 | CA2350830A1 Hypoxia-inducible factor 1.alpha. hif-1.alpha. variants and methods for identifying hif-1.alpha. modulators |
05/25/2000 | CA2350785A1 31 human secreted proteins |
05/25/2000 | CA2350698A1 Human glycine transporter type 2 |
05/25/2000 | CA2350623A1 Mammalian chondromodulin-like protein |
05/25/2000 | CA2350603A1 Ring finger protein zapop3 |
05/25/2000 | CA2350415A1 Inflammation-associated genes |
05/25/2000 | CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
05/25/2000 | CA2350389A1 Calcium binding protein |
05/25/2000 | CA2350228A1 Novel g protein-coupled receptor protein, its dna and ligand thereof |
05/25/2000 | CA2350186A1 Promoters for gene expression in the roots of plants |
05/25/2000 | CA2350139A1 Methods of making modified nucleosides |
05/25/2000 | CA2350124A1 A sensitive screening system for envelope-defective recombinant virus |
05/25/2000 | CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species |
05/25/2000 | CA2350079A1 Udp-galactose: beta-n-acetyl-glucosamine beta1,3galactosyltransferases. beta3gal-t5 |
05/25/2000 | CA2350078A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
05/25/2000 | CA2349869A1 Novel protein and utilization thereof |
05/25/2000 | CA2349837A1 Lysozyme fusion proteins in infections |
05/25/2000 | CA2349762A1 Human tslp dna and polypeptides |
05/25/2000 | CA2349618A1 Compositions and methods relating to the peroxisomal proliferator activated receptor-.alpha. mediated pathway |
05/25/2000 | CA2349588A1 Endoplasmic reticulum stress transcription factors atf6 and creb-rp |